Merck Operating Income 2010-2024 | MKKGY

Merck annual/quarterly operating income history and growth rate from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Merck operating income for the quarter ending December 31, 2024 was $0.874B, a 30.99% increase year-over-year.
  • Merck operating income for the twelve months ending December 31, 2024 was $3.945B, a 0.98% increase year-over-year.
  • Merck annual operating income for 2024 was $3.945B, a 0.98% increase from 2023.
  • Merck annual operating income for 2023 was $3.907B, a 17.11% decline from 2022.
  • Merck annual operating income for 2022 was $4.714B, a 4.64% decline from 2021.
Merck Annual Operating Income
(Millions of US $)
2024 $3,945
2023 $3,907
2022 $4,714
2021 $4,943
2020 $3,410
2019 $2,374
2018 $2,038
2017 $2,854
2016 $2,747
2015 $2,045
2014 $2,342
2013 $2,893
2012 $1,984
2011 $1,555
2010 $12,338
2009 $10,807
Merck Quarterly Operating Income
(Millions of US $)
2024-12-31 $874
2024-09-30 $1,206
2024-06-30 $854
2024-03-31 $1,011
2023-12-31 $667
2023-09-30 $1,071
2023-06-30 $1,058
2023-03-31 $1,111
2022-12-31 $904
2022-09-30 $1,244
2022-06-30 $1,249
2022-03-31 $1,316
2021-12-31 $1,186
2021-09-30 $1,236
2021-06-30 $1,264
2021-03-31 $1,257
2020-12-31 $716
2020-09-30 $1,363
2020-06-30 $541
2020-03-31 $790
2019-12-31 $572
2019-09-30 $678
2019-06-30 $695
2019-03-31 $429
2018-12-31 $361
2018-09-30 $571
2018-06-30 $469
2018-03-31 $638
2017-12-31 $301
2017-09-30 $1,058
2017-06-30 $691
2017-03-31 $805
2016-12-31 $433
2016-09-30 $754
2016-06-30 $622
2016-03-31 $937
2015-12-31 $329
2015-09-30 $644
2015-06-30 $554
2015-03-31 $573
2014-12-31 $112
2014-09-30 $569
2014-06-30 $504
2014-03-31 $644
2013-12-31 $539
2013-09-30 $830
2013-06-30 $870
2013-03-31 $643
2012-12-31 $3,646
2012-09-30 $601
2012-06-30 $79
2012-03-31 $3,274
2011-12-31 $3,311
2011-09-30 $3,585
2011-06-30 $151
2011-03-31 $3,505
2010-12-31 $3,707
2010-09-30 $618
2010-06-30 $2,695
2010-03-31 $2,791
2009-12-31 $2,983
2009-09-30 $2,778
2009-06-30 $2,590
2009-03-31 $2,456
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $17.021B $22.569B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $89.384B 33.53
Zoetis (ZTS) United States $75.427B 28.14
Daiichi Sankyo, - (DSNKY) Japan $51.906B 26.41
Takeda Pharmaceutical (TAK) Japan $47.983B 9.54
Sandoz Group AG (SDZNY) Switzerland $22.594B 0.00
United Therapeutics (UTHR) United States $14.681B 12.99
Shionogi (SGIOY) Japan $14.275B 14.30
Summit Therapeutics (SMMT) United States $13.164B 0.00
Neurocrine Biosciences (NBIX) United States $12.327B 42.22
IPSEN (IPSEY) France $10.095B 0.00
Orion OYJ (ORINY) Finland $9.462B 25.59
Corcept Therapeutics (CORT) United States $7.601B 61.79
Stevanato Group S.p.A (STVN) Italy $6.638B 40.59
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.054B 0.00
Grifols, S.A (GRFS) Spain $5.707B 0.00
Ionis Pharmaceuticals (IONS) United States $5.429B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.813B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.037B 10.64
Crinetics Pharmaceuticals (CRNX) United States $2.985B 0.00
Hypermarcas (HYPMY) Brazil $2.724B 17.92
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.326B 12.58
BioCryst Pharmaceuticals (BCRX) United States $2.245B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.125B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.791B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.776B 0.00
Indivior (INDV) United States $1.718B 7.29
Dyne Therapeutics (DYN) United States $1.444B 0.00
ARS Pharmaceuticals (SPRY) United States $1.420B 0.00
Evotec AG (EVO) Germany $1.413B 0.00
Guardian Pharmacy Services (GRDN) United States $1.347B 0.00
Ocular Therapeutix (OCUL) United States $1.292B 0.00
Harrow (HROW) United States $1.100B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.075B 21.51
Collegium Pharmaceutical (COLL) United States $0.942B 5.08
Enliven Therapeutics (ELVN) United States $0.939B 0.00
Ardelyx (ARDX) United States $0.921B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.918B 0.00
Akebia Therapeutics (AKBA) United States $0.854B 0.00
Xeris Biopharma Holdings (XERS) United States $0.790B 0.00
Cronos Group (CRON) Canada $0.740B 0.00
AleAnna (ANNA) United States $0.647B 0.00
KalVista Pharmaceuticals (KALV) United States $0.642B 0.00
Xencor (XNCR) United States $0.611B 0.00
Elite Pharmaceuticals (ELTP) United States $0.571B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.558B 0.00
Regulus Therapeutics (RGLS) United States $0.550B 0.00
Relay Therapeutics (RLAY) United States $0.545B 0.00
USANA Health Sciences (USNA) United States $0.544B 11.83
Bioventus (BVS) United States $0.529B 13.42
Zevra Therapeutics (ZVRA) United States $0.474B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.455B 0.00
Oruka Therapeutics (ORKA) United States $0.441B 0.00
Tourmaline Bio (TRML) United States $0.439B 0.00
Siga Technologies (SIGA) United States $0.434B 9.07
Altimmune (ALT) United States $0.430B 0.00
Verve Therapeutics (VERV) United States $0.427B 0.00
Savara (SVRA) United States $0.415B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.360B 9.73
Organogenesis (ORGO) United States $0.337B 0.00
Heron Therapeutics (HRTX) United States $0.294B 0.00
Aquestive Therapeutics (AQST) United States $0.279B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.279B 0.00
Nature's Sunshine Products (NATR) United States $0.258B 23.80
MediWound (MDWD) Israel $0.240B 0.00
ProKidney (PROK) United States $0.218B 0.00
Nanobiotix S.A (NBTX) France $0.193B 0.00
Esperion Therapeutics (ESPR) United States $0.182B 0.00
Journey Medical (DERM) United States $0.182B 0.00
4D Molecular Therapeutics (FDMT) United States $0.174B 0.00
OmniAb (OABI) United States $0.172B 0.00
Profound Medical (PROF) Canada $0.165B 0.00
Avita Medical (RCEL) United States $0.160B 0.00
Aclaris Therapeutics (ACRS) United States $0.156B 0.00
Inhibikase Therapeutics (IKT) United States $0.152B 0.00
Nektar Therapeutics (NKTR) United States $0.148B 0.00
Larimar Therapeutics (LRMR) United States $0.141B 0.00
Liminatus Pharma (LIMN) $0.140B 0.00
Achieve Life Sciences (ACHV) Canada $0.135B 0.00
Wellgistics Health (WGRX) United States $0.135B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.134B 0.00
Protara Therapeutics (TARA) United States $0.127B 0.00
Aldeyra Therapeutics (ALDX) United States $0.127B 0.00
Lyell Immunopharma (LYEL) United States $0.122B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Cassava Sciences (SAVA) United States $0.103B 0.00
VAXART, INC (VXRT) United States $0.103B 0.00
Cardiol Therapeutics (CRDL) Canada $0.102B 0.00
Korro Bio (KRRO) United States $0.101B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.101B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Inotiv (NOTV) United States $0.093B 0.00
Fractyl Health (GUTS) United States $0.093B 0.00
Nutriband (NTRB) United States $0.090B 0.00
Lexeo Therapeutics (LXEO) United States $0.090B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.090B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.085B 63.44
Galectin Therapeutics (GALT) United States $0.082B 0.00
Unicycive Therapeutics (UNCY) United States $0.080B 0.00
Champions Oncology (CSBR) United States $0.079B 13.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Pyxis Oncology (PYXS) United States $0.076B 0.00
Vivani Medical (VANI) United States $0.073B 0.00
Surrozen (SRZN) United States $0.070B 0.00
Metagenomi (MGX) United States $0.066B 0.00
Dominari Holdings (DOMH) United States $0.066B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
Telomir Pharmaceuticals (TELO) United States $0.063B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.058B 0.00
Context Therapeutics (CNTX) United States $0.053B 0.00
Prelude Therapeutics (PRLD) United States $0.051B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.050B 0.00
Avalo Therapeutics (AVTX) United States $0.047B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
NRx Pharmaceuticals (NRXP) United States $0.046B 0.00
PMV Pharmaceuticals (PMVP) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Rafael Holdings (RFL) United States $0.037B 0.00
Karyopharm Therapeutics (KPTI) United States $0.036B 0.00
Acrivon Therapeutics (ACRV) United States $0.035B 0.00
SCYNEXIS (SCYX) United States $0.035B 0.00
PolyPid (PYPD) Israel $0.030B 0.00
FibroGen (FGEN) United States $0.030B 0.00
Jupiter Neurosciences (JUNS) United States $0.027B 0.00
Lyra Therapeutics (LYRA) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Relmada Therapeutics (RLMD) United States $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
China SXT Pharmaceuticals (SXTC) China $0.021B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Mannatech (MTEX) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
DURECT (DRRX) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
BioLineRx (BLRX) Israel $0.014B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Ainos (AIMD) United States $0.013B 0.00
GlycoMimetics (GLYC) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.011B 1.90
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
SHINECO (SISI) China $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00